Audicus Omni 2 vs Otofonix Groove

The Audicus Omni 2 is a premium-priced behind-the-ear OTC hearing aid available for $1,898. With a SoundScore of 4.6/5 and an A grade, it ranks #5 among 65 OTC hearing aids tested, placing it in the top 6% of its category. In our lab testing, the Omni 2 demonstrates strong speech clarity in quiet environments, scoring 4.2/5—well above the category average by 1.38 points. Speech in noise performance is more modest at 2.3/5, which is above the category average by 0.79 points but mixed in absolute terms. This pattern suggests the device handles everyday conversations well while challenging listening situations may still present difficulty. Music streaming is a particular strength, scoring 3.6/5 and exceeding the category average by a substantial 1.68 points. Feedback handling is excellent at 4.5/5, virtually matching the category average. Own-voice comfort scores a solid 3.0/5, which is 0.49 points above average for OTC devices. The Omni 2 offers both rechargeable and disposable battery options, along with streaming compatibility for iPhone and Android devices with hands-free capability. It has earned Expert's Choice Awards for both 2023 and 2024. Consumers seeking alternatives in this price range may also consider the similarly-priced Lucid Tala, while the lower-priced Lexie B3 offers competitive performance for those with tighter budgets.

The Otofonix Groove is a behind-the-ear prescription hearing aid priced at $795, earning a C grade with a SoundScore of 2.7/5 in our lab testing. This rechargeable BTE ranks #38 of 39 devices in the prescription hearing aid category, placing it in the bottom 5% of its class. In our testing, the Groove demonstrated excellent feedback handling at 5.0/5, scoring 0.28 points above the category average. This represents a genuine strength, with the device maintaining stability during our standardized challenge motions. However, speech performance was significantly limited, with speech in quiet scoring 1.0/5 (2.40 points below the category average of 3.40) and speech in noise also at 1.0/5 (1.11 points below average). Music streaming was not functional in our tests, scoring 0.0/5 against a category average of 2.76. Own-voice comfort also fell well below typical prescription hearing aid performance at 0.4/5, which is 2.30 points below the category average. At this price point, several lower-cost alternatives delivered stronger overall performance in our testing. Consumers seeking value in the prescription category may want to explore other options, though those requiring robust feedback control in a rechargeable BTE format may find the Groove's stability noteworthy despite its other limitations.